12.06.2014 Views

Impact - The Jimmy Fund

Impact - The Jimmy Fund

Impact - The Jimmy Fund

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Learn more about the Mission Possible Campaign at dana-farber.org/campaign.<br />

Renowned philanthropist’s newest cause hits close to home<br />

PMC continued from page 1<br />

For more than a decade, Steven Kirsch has given tens of millions of dollars<br />

to support medical research, education, environmental protection, and<br />

community-based charities. Committed to making the greatest possible<br />

impact with his gifts, he has always placed a premium on finding and supporting<br />

underfunded yet worthwhile<br />

projects. In August 2007, he found<br />

just such a cause in Waldenström’s<br />

macroglobulinemia—only this time,<br />

it was personal.<br />

“I had never heard of<br />

Waldenström’s before I was<br />

diagnosed with it,” he said. “I had<br />

to crack open the textbooks and do<br />

some research.”<br />

Kirsch was appalled to learn the<br />

deadly blood cancer receives almost<br />

no attention from government<br />

funding agencies or pharmaceutical<br />

companies because it is relatively<br />

rare. Scarce funding means few<br />

scientists study this “orphan”<br />

disease and, therefore, relatively few<br />

treatment options exist for patients.<br />

Determined to change that,<br />

Kirsch began a nationwide search<br />

for the most promising researchers<br />

in the field. He quickly decided<br />

on the only center in the world<br />

Michele and Steven Kirsch hope their support of Waldenström’s<br />

macroglobulinemia research will produce lifesaving treatments<br />

for patients with this rare disease.<br />

<strong>The</strong> good fight<br />

focused specifically on this disease:<br />

Dana-Farber’s Bing Center for<br />

<strong>The</strong> community of Middleton, Mass., came together to honor one of their own with<br />

Jack Fights Back, an inaugural event to raise funds for neuroblastoma research at<br />

Dana-Farber. Held April 6 at the Danversport Yacht Club in Danvers, Mass., the benefit<br />

was organized by Ron and Kim Supino, whose 9-year-old son Jack has successfully<br />

battled this cancer of the nervous system.<br />

Originally expecting a modest turnout, the Supinos were moved by the mass of neighbors<br />

and friends who attended, as well as local businesses that contributed more than<br />

70 items for the raffle and silent auction. At the end of the day, this swell of support<br />

carried Jack Fights Back to a fundraising total of more than $100,000—four times<br />

more than initial expectations.<br />

According to the family, no one was happier with the outcome than Jack himself<br />

(above), who, at one point during the event, took center stage for an impromptu<br />

performance of Elvis Presley’s “Jailhouse Rock.”<br />

Waldenström’s Macroglobulinemia. Impressed by what he saw, Kirsch and his<br />

wife, Michele, have given Dana-Farber $1 million to support the work of Irene<br />

Ghobrial, MD, in the Bing Center.<br />

In recognition of the Kirsches’ generosity, Ghobrial’s laboratory within the<br />

Bing Center has been named the Michele and Steven Kirsch Laboratory for<br />

Waldenström’s Research.<br />

<strong>The</strong> gift also represents an important contribution to Mission Possible: <strong>The</strong><br />

Dana-Farber Campaign to Conquer Cancer.<br />

A two-pronged attack<br />

When deciding which specific projects to fund, Kirsch was particularly drawn<br />

to Ghobrial’s work. One of the greatest obstacles in combating the disease is the<br />

ability of Waldenström’s macroglobulinemia cells to hide out in a patient’s bone<br />

marrow where they are protected from drugs designed to destroy them. Much of<br />

Ghobrial’s research focuses both on understanding how the cancer cells gain entry<br />

into the bone marrow and identifying drugs to force them out of their hiding<br />

places. Using such drugs, she hopes to first “smoke out” the cancer cells and then<br />

kill them with other treatments.<br />

“It’s a nice one-two combination,” said Kirsch. “<strong>The</strong> approach she’s taking<br />

appears the most promising to me.”<br />

In addition to supporting clinical trials based on this strategy, the Kirsch gift<br />

will fuel studies designed to help researchers better understand the basic biology<br />

of the disease and the causes of its progression. It will also fund projects aimed at<br />

identifying new drug targets and transforming that knowledge into novel therapies<br />

as quickly as possible.<br />

Without the Kirsches’ crucial support, many of these promising endeavors<br />

would never get off the ground.<br />

“<strong>The</strong> government doesn’t usually give much money for Waldenström’s<br />

macroglobulinemia research,” said Ghobrial. “This gift is huge in terms of helping<br />

me push our research forward.” n<br />

Bailey gift zeroes in on genetic<br />

roots of rare blood cancer<br />

When Robert “Bob” Bailey was first<br />

diagnosed with Waldenström’s<br />

macroglobulinemia in 1997, few<br />

treatments existed for this unusual illness. In the<br />

decade that followed, his therapeutic options grew,<br />

thanks in large part to Steven Treon, MD, PhD,<br />

director of the Bing Center for Waldenström’s<br />

Macroglobulinemia at Dana-Farber.<br />

“Dr. Treon has done so much for people with<br />

this disease,” said Bailey’s wife, Laura. “Because<br />

of him, there are now treatments that we never<br />

would have thought possible 10 years ago.”<br />

Hoping to build on that success, the Baileys<br />

have given Dana-Farber $750,000 to fund<br />

Treon’s research into the genetics of the rare<br />

blood cancer.<br />

In previous studies, Treon and his colleagues<br />

identified Waldenström’s patients with a family<br />

history of blood cell abnormalities. This subset<br />

of patients may have inherited genetic risk<br />

Robert “Bob” Bailey’s positive experience as a<br />

Dana-Farber patient inspired him and his wife,<br />

Laura, to support Waldenström’s macroglobulinemia<br />

research under the direction of Steven Treon,<br />

MD, PhD (above).<br />

factors that contribute to the development of the disease. With support from the<br />

Bailey Family <strong>Fund</strong>, Treon plans to study these patients and their families in the<br />

hopes of identifying specific genes underlying the illness—information that might<br />

yield important clues about what causes the cancer and how to treat<br />

it more effectively.<br />

“Research on this rare disease is chronically underfunded,” said Treon.<br />

“Without the generous support of people like the Baileys, important projects of<br />

this kind might never move ahead.”<br />

Research and care are major funding priorities of Mission Possible: <strong>The</strong> Dana-<br />

Farber Campaign to Conquer Cancer, and Bailey’s gift supports this<br />

$1 billion fundraising initiative.<br />

Bob Bailey’s survival 11 years after diagnosis is a testament to the power<br />

of DFCI’s ability to rapidly translate discoveries into new therapies to benefit<br />

patients. Already having lived longer than most people with his disease, he believes<br />

the development of new therapies has been crucial in helping him beat the odds.<br />

With this gift, the Baileys hope Treon will one day produce even better treatments,<br />

improving the odds for all Waldenström’s macroglobulinemia patients.<br />

“Obviously, we’re interested in helping a lot of people with this disease,” said<br />

Bob Bailey. “Dr. Treon is the right person, doing the right research, right now.” n<br />

line to collectively raise an anticipated, record-breaking $34 million.<br />

<strong>The</strong> PMC, founded in 1980 by Executive Director and Institute Trustee Billy<br />

Starr, is the largest athletic fundraising event in the nation. It is so well known<br />

that it now draws people from 36 states and eight countries who want to make a<br />

difference in the lives of cancer patients around the globe.<br />

“We at the PMC relish the role we play at Dana-Farber,” said Starr. “We feel<br />

challenged, but capable, of providing this incredible annual gift and, at the same<br />

time, challenged and flattered to find the room for all who want to participate in<br />

this amazing weekend event.”<br />

Thriving and surviving<br />

Paul Schaye, a devoted extreme-sports athlete and Boston native, has participated<br />

in the PMC for 10 years. His team, “Paul’s Posse,” has raised more than $712,000<br />

over the past two years alone. In October 2006, his reason for riding became more<br />

personal: He was diagnosed with stage IV stomach cancer.<br />

“In the past, I rode to help raise money for cancer research, but I never<br />

imagined I would ride as a possible beneficiary of that research,” he said.<br />

Referring to himself as a “cancer thriver,” Schaye faced his treatment with the<br />

same positive power he put into all of his athletic challenges. After major surgery<br />

in November 2007 and with the assistance of the “smart” drug Gleevec®, Paul<br />

remains disease-free. To celebrate this year, he again made the 190-mile journey<br />

with his Paul’s Posse teammates by his side.<br />

“We at the PMC relish the role we play <br />

at Dana-Farber.”<br />

— Institute Trustee Billy Starr<br />

<strong>The</strong> next generation<br />

<strong>The</strong> PMC has rapidly become an event for participants of all ages. Since 1998, the<br />

PMC Kids Ride Program has offered children between the ages of 3 and 15, as<br />

well as their parents and neighbors, the opportunity to create individual bike-athons,<br />

including a short obstacle course for tykes on tricycles and a 26-mile trek<br />

for teens.<br />

“Through these mini bike-a-thons, we are teaching children the benefits of<br />

being active and helping others,” Starr said. “<strong>The</strong> PMC Kids Ride Program is the<br />

future of the PMC.”<br />

In 2008, 30 kids rides were held and are expected to raise $750,000 toward the<br />

PMC’s impressive $34 million goal. n<br />

Left to right: Paul’s Posse team leader Paul Schaye celebrates being a “cancer thriver” with fellow<br />

teammates George Demetri, MD, director of DFCI’s Center for Sarcoma and Bone Oncology, Demetri’s<br />

daughter, Leah Demetri, and Julie Pokela.<br />

Cycling toward cancer cures<br />

More than 300 bicyclists pedaled along four different routes throughout Western<br />

Massachusetts as part of Katelynn’s Ride. Held June 8, the 8th annual fundraiser, which is<br />

affiliated with the Pan-Massachusetts Challenge bike-a-thon, raised $165,000 to benefit<br />

groundbreaking research and treatment at Dana-Farber Cancer Institute. This year’s success<br />

has helped the program surpass $1 million in cumulative fundraising since its inception.<br />

Katelynn’s Ride began in 2000 to honor 11-year-old Katelynn Battista, a <strong>Jimmy</strong> <strong>Fund</strong><br />

Clinic patient who lost her battle against cancer in 1997. Moved by her story, Steve<br />

Stark, of the United States Postal Service, and radio personalities Dan Williams and Kim<br />

Zachary of Mix 93.1-FM in Springfield, Mass., organized the event in her memory.<br />

Right: With his parents, Domenic and Michele Battista, by his side, Luke Battista kicked<br />

off this year’s festivities by cutting the ribbon at the starting line at Hampshire College in<br />

Amherst, Mass.<br />

One PMC cyclist shows his enthusiasm for fighting cancer while pedaling along one of the bike-a-thon’s<br />

various routes.<br />

Left to right: NECN television anchor R.D. Sahl speaks with PMC Founder and Executive Director and<br />

Institute Trustee Billy Starr during the event’s opening ceremonies, which included a check presentation<br />

from younger riders of the PMC Kids Ride.<br />

6 <strong>Impact</strong> SUMMER 2008<br />

<strong>Impact</strong> SUMMER 2008 7

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!